Development and optimization of a DNA-based reverse genetics systems for epizootic hemorrhagic disease virus
dc.contributor.author | Guo, Yunze | |
dc.contributor.author | Pretorius, Jakobus Maree | |
dc.contributor.author | Xu, Qingyuan | |
dc.contributor.author | Wu, Donglai | |
dc.contributor.author | Bu, Zhigao | |
dc.contributor.author | Theron, Jacques | |
dc.contributor.author | Sun, Encheng | |
dc.date.accessioned | 2021-11-24T13:13:56Z | |
dc.date.available | 2021-11-24T13:13:56Z | |
dc.date.issued | 2020-05 | |
dc.description.abstract | Epizootic hemorrhagic disease virus (EHDV) is a member of the genus Orbivirus, family Reoviridae, and has a genome consisting of 10 linear double-stranded (ds) RNA segments. The current reverse genetics system (RGS) for engineering the EHDV genome relies on the use of in vitro-synthesized capped viral RNA transcripts. To obtain more-efficient and simpler RGSs for EHDV, we developed an entirely DNA (plasmid or PCR amplicon)-based RGS for viral rescue. This RGS enabled the rescue of infectious EHDV from BSR-T7 cells following co-transfection with seven helper viral protein expression plasmids and 10 cDNA rescue plasmids or PCR amplicons representing the EHDV genome. Furthermore, we optimized the DNA-based systems and confirmed that some of the helper expression plasmids were not essential for the recovery of infectious EHDV. Thus, DNA-based RGSs may offer a more efficient method of recombinant virus recovery and accelerate the study of the biological characteristics of EHDV and the development of novel vaccines. | en_ZA |
dc.description.department | Biochemistry | en_ZA |
dc.description.department | Genetics | en_ZA |
dc.description.department | Microbiology and Plant Pathology | en_ZA |
dc.description.librarian | hj2021 | en_ZA |
dc.description.sponsorship | The National Key R&D Program of China and the Central Public-Interest Scientific Institution Basal Fund. | en_ZA |
dc.description.uri | http://link.springer.com/journal/705 | en_ZA |
dc.identifier.citation | Guo, Y., Pretorius, J.M., Xu, Q. et al. Development and optimization of a DNA-based reverse genetics systems for epizootic hemorrhagic disease virus. Archives of Virology 165, 1079–1087 (2020). https://doi.org/10.1007/s00705-020-04583-w. | en_ZA |
dc.identifier.issn | 0304-8608 (print) | |
dc.identifier.issn | 1432-8798 (online) | |
dc.identifier.other | 10.1007/s00705-020-04583-w | |
dc.identifier.uri | http://hdl.handle.net/2263/82817 | |
dc.language.iso | en | en_ZA |
dc.publisher | Springer | en_ZA |
dc.rights | © 2020, Springer-Verlag GmbH Austria, part of Springer Nature. The original publication is available at : http://link.springer.comjournal/705. | en_ZA |
dc.subject | Epizootic hemorrhagic disease virus (EHDV) | en_ZA |
dc.subject | Reverse genetics system (RGS) | en_ZA |
dc.subject | Viral RNA transcripts | en_ZA |
dc.subject | DNA-based reverse genetics systems | en_ZA |
dc.title | Development and optimization of a DNA-based reverse genetics systems for epizootic hemorrhagic disease virus | en_ZA |
dc.type | Postprint Article | en_ZA |